The results in the two nasopharyngeal carcinoma lines showed that the complexes immunoprecipitated by the two anti-SOX2 antibodies were enriched in the ANRIL promoter DNA fragment, compared with the isotype antibody control. Here, CDKN2B-AS1 is linked to nasopharyngeal carcinoma.